vitamins A, B, C, E, B6, B12, folate, zinc, iron, copper, and selenium
S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In S... - 0 views
62More
The Role of Vitamin C in Human Immunity and Its Treatment Potential Against COVID-19: A... - 0 views
-
White blood cells, including neutrophils and monocytes, accumulate concentrations of vitamin C up to 100 times greater than that of plasma
-
Vitamin C is a crucial component of both the innate (nonspecific) and adaptive (specific) portions of the immune system
- ...52 more annotations...
-
maturation, proliferation, and viability of T cells have all been shown to be upregulated by the presence of normal physiologic concentrations of vitamin C
-
vitamin C among healthy young adult males showed a significant increase in serum levels of IgA, IgG, and IgM
-
effects of high-dose vitamin C on cytokine levels in cancer patients, finding decreased amounts of the cytokines Interleukin-1 alpha (IL-1 alpha), IL-2, IL-8, and tumor necrosis factor-alpha (TNF-alpha) after high-dose vitamin C infusion
-
when vitamin C was supplemented with vitamin E in healthy adults, it increased the production of cytokines IL-1 beta and TNF-alpha
-
vitamin C acts to modulate the levels of cytokines to prevent them from fluctuating in either direction
-
human leukocytes, neutrophils, in particular, possess the ability to transport the oxidized form of vitamin C across its membrane to use as a defense mechanism against ROS produced during an immune response
-
Vitamin C also can recover other endogenous antioxidants in the body such as vitamin E and glutathione, returning them to their active state
-
can reduce harmful nitrogen-based compounds such as N-nitrosamines and nitrosamides, both of which are carcinogenic
-
subjects taking oral vitamin C supplementation saw a 60% to 90% reduction in oxidative stress compared to a placebo control
-
subjects infused with vitamin C alone had a 516% increase in glutathione levels compared to subjects not provided the 500 mg daily supplementation
-
Studies have demonstrated that those with low levels of vitamin C are at a significantly higher risk of respiratory infection compared to those with normal levels
-
viral cold duration was reduced by about 8% in adults and 13.5% in children using prophylactic daily doses of 200 mg of oral vitamin C
-
prophylactically supplementing vitamin C decreases the risk of infection with respiratory viruses such as the common cold
-
combined with probiotics, oral vitamin C supplementation showed a 33% decrease in the incidence of respiratory tract infections in preschool-age children [
-
high-dose oral supplementation of vitamin C managed to prevent or reduce symptoms if taken before or just after the onset of cold- or flu-like symptoms
-
improvements in oxygen saturation and decreased IL-6 levels (a marker of inflammation) in the treatment group compared to the control group
-
Patients with COVID-19 will likely also experience depletion in serum levels of vitamin C as a direct result of the upregulation of the immune system to combat the infection
-
Colunga et al. suggested that oral vitamin C can be combined with oral Quercetin, an antiviral flavonoid, to improve Quercetin’s ability to block viral membrane fusion of SARS-CoV-2
-
It appears vitamin C supplementation by itself does not provide a striking benefit in preventing COVID-19 infection for those without a deficiency
-
some evidence to support that prophylactic use of vitamin C helps reduce the severity of respiratory infection symptoms once a subject has already been infected
-
other studies were unable to find any definitive improvement concerning therapy with vitamin C
-
Fowler et al. aimed to see if a high-dose vitamin C infusion would benefit patients affected by ARDS, but they were unable to conclude that vitamin C infusion, compared to a placebo, could decrease vascular inflammation and damage in ARDS
-
in a sample of 67 COVID-19-positive ICU patients, 82% of them displayed plasma vitamin C levels below 0.4 mg/dL
-
continuous vitamin C infusion at a rate of 60 mg/kg/day for four days decreased the need for mechanical ventilation and vasopressor use but had no significant effect on overall mortality
-
Carr et al. suggested that high-dose IV vitamin C is most effective when treating sepsis as septic patients receiving the normal daily recommendations through diet still showed decreased vitamin C levels
-
High-dose IV vitamin C treatment has also been shown by Kakodkar et al. to decrease syndecan-1, an endothelial glycocalyx that contributes to mortality in septic patients
-
combined with hydrocortisone and thiamine, septic patients treated with 1.5 g of IV vitamin C every six hours showed a distinct decrease in their SOFA scores and none of the patients treated developed organ failure
-
combined with hydrocortisone and thiamine, septic patients treated with 1.5 g of IV vitamin C every six hours showed a distinct decrease in their SOFA scores and none of the patients treated developed organ failure
-
treatment of severe sepsis using a high dose (up to 200 mg/kg/day) of IV vitamin C was explored in phase I, a double-blind, randomized, placebo-controlled trial by Fowler et al. [75]. Their findings included a reduction in SOFA scores and decreased vascular injury compared to a placebo control group, all while showing minimal adverse side effects
-
Maintaining a daily intake of 75 and 100 mg for men and women, respectively, as recommended by the U.S. Institute of Medicine
95More
shared by Nathan Goodyear on 01 Sep 23
- No Cached
Toxicity of the spike protein of COVID-19 is a redox shift phenomenon: A novel therapeu... - 0 views
www.sciencedirect.com/...S0891584923005014
COVID19 COVID-19 cancer inflammation SARS-CoV-2 spike proteins COVID spikeopathy

- ...88 more annotations...
-
Long-term effects include redox shift and cellular anabolism as a result of the Warburg effect and mitochondrial dysfunction
-
Long-term effects include redox shift and cellular anabolism as a result of the Warburg effect and mitochondrial dysfunction
-
Long-term effects include redox shift and cellular anabolism as a result of the Warburg effect and mitochondrial dysfunction
-
Long-term effects include redox shift and cellular anabolism as a result of the Warburg effect and mitochondrial dysfunction
-
Lipoic acid and Methylene Blue have been shown to enhance the mitochondrial activity, relieve the Warburg effect and increase catabolism
-
Lipoic acid and Methylene Blue have been shown to enhance the mitochondrial activity, relieve the Warburg effect and increase catabolism
-
Lipoic acid and Methylene Blue have been shown to enhance the mitochondrial activity, relieve the Warburg effect and increase catabolism
-
Methylene Blue, Chlorine dioxide and Lipoic acid may help reduce long-term Covid-19 effects by stimulating the catabolism
-
Methylene Blue, Chlorine dioxide and Lipoic acid may help reduce long-term Covid-19 effects by stimulating the catabolism
-
Methylene Blue, Chlorine dioxide and Lipoic acid may help reduce long-term Covid-19 effects by stimulating the catabolism
-
direct consequence of redox iMeBalance, itself a consequence of decreased energy yield by the mitochondria
-
direct consequence of redox iMeBalance, itself a consequence of decreased energy yield by the mitochondria
-
mitochondrial dysfunction and increased levels of lactate, which are important characteristics of metabolic shift and Warburg effect in many diseases
-
mitochondrial dysfunction and increased levels of lactate, which are important characteristics of metabolic shift and Warburg effect in many diseases
-
cell division is the most sophisticated way to release entropy
-
redox signaling plays an important role in regulating immune function and inflammation, and disruptions in this signaling can lead to excessive cytokine production and immune system activation
-
reduced extracellular environment in the elderly and the increased susceptibility to Covid-19 infection
-
reduced extracellular environment in the elderly and the increased susceptibility to Covid-19 infection
-
Redox signaling tightly modulates the inflammatory response and oxidative stress has been reported in acute Covid-19
-
People at high risk are the elderly, patients suffering from metabolic syndrome such as obesity, or those suffering from chronic diseases such as cancer or inflammation
-
COVID-19 patients with severe disease have higher levels of oxidative stress markers and lower antioxidant levels
-
oxidative stress can activate the NLRP3 inflammasome, which is a protein complex that plays a key role in the cytokine storm
-
inflammation leads to the formation of ROS and RNS, while redox iMeBalance results in cellular damage, which in turn triggers an inflammatory response
-
persistently elevated mtROS triggers endothelial dysfunction and inflammation, which results in a vicious loop involving ROS, inflammation, and mitochondrial dysfunction
-
IL-2 is highly up-regulated in Covid-19 patients [37], and IL-2 is known to significantly stimulate the generation of NO in patients
-
Elevated levels of lactate, a characteristic of the Warburg effect, were also reported in the high-risk Covid-19
-
vaccinated with RNA or DNA vaccines triggering the synthesis of the viral spike protein in human cells
-
viral reactivation in varicella-zoster virus [55] or hepatitis [56], coagulopathy and resulting stroke and myocarditis following both DNA-based vaccines [57] and RNA-based vaccines
-
characteristic of the Warburg effect is present in almost every disease and appears to be a central feature in most of the hallmarks of cancer
-
inflammation, mitochondrial dysfunction and increased lactate concentrations in the extracellular fluid
-
As the mitochondria are impaired, the infected cell cannot catabolize efficiently. It will release lactic acid in the blood stream
-
Striking similarities are seen between cancer, Alzheimer's disease and Covid-19, all related to the Warburg effect
-
Cancer, inflammation, Alzheimer's, and Parkinson's diseases share a common peculiarity, the inability of the cell to export entropy outside the body in the harmless form of heat
-
MEB relieves the Warburg effect [87], improves memory [77], is active in the treatment of depressive episodes [79,80] and reduces the importance of ischemic strokes
-
MEB relieves the Warburg effect [87], improves memory [77], is active in the treatment of depressive episodes [79,80] and reduces the importance of ischemic strokes
-
It has been shown that Covid-19-patients treated with MEB, have a significant reduction in hospital stay duration and mortality
-
MeB + can take a pair of electrons (of H atoms) and MeBH can release this pair easily, so that MeB is partially recycled like a catalyst
-
MeB acts as an electron bridge between a donor (FADH2, FMNH, NADH) and an acceptor (complex IV of ETC or oxygen itself)
-
As a coenzyme of pyruvate dehydrogenase (PDH), alpha-lipoic acid (ALA) initiates the formation of acetyl-CoA to feed the TCA cycle
-
ALA enhances the catabolism of carbon. cycle and therefore may reduce the Warburg effect and consequently, lactate production
-
Methylene Blue plays a similar role after the TCA cycle, by carrying electrons to complex IV of the electron transport chain
-
Drugs such as lipoic acid and MeB, which target the metabolism, decrease the redox shift by increasing catabolism
Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor - PMC - 0 views
www.ncbi.nlm.nih.gov/...PMC8173196
gut microbiome gut flora immune system diet gut microbiota gut bacteria nutrition

The Hallmarks of Cancer: Cell - 0 views
2More
shared by Nathan Goodyear on 01 Sep 23
- No Cached
The SARS-CoV-2 Spike Protein Activates the Epidermal Growth Factor Receptor-Mediated Si... - 0 views
europepmc.org/...37112680
COVID19 Wnt_Beta catenin survivin EGFR Wnt cancer COVID ERK SARS-CoV-2 COVID-19

-
we wanted to investigate if other molecular targets and pathways may be used by SARS-CoV-2. We investigated the possibility of the spike 1 S protein and its receptor-binding domain (RBD) to target the epidermal growth factor receptor (EGFR) and its downstream signaling pathway in vitro using the lung cancer cell line (A549 cells). Protein expression and phosphorylation were examined upon cell treatment with the recombinant full spike 1 S protein or RBD. We demonstrate for the first time the activation of EGFR by the Spike 1 protein associated with the phosphorylation of the canonical Extracellular signal-regulated kinase1/2 (ERK1/2) and AKT kinases and an increase in survivin expression controlling the survival pathway.
1More
MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccina... - 0 views
14More
'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA -... - 0 views
-
toxicity of the spike protein—both from the virus and also when produced by gene codes in the novel COVID-19 mRNA and adenovectorDNA vaccines
-
A central issue has been growing evidence of pathogenic effects of the SARS-CoV-2 spike protein—whether as part of the virus or produced by genetic codes in the mRNA and adenovectorDNA vaccines
- ...10 more annotations...
-
It is apparent that the original Wuhan strain and early variants of SARS-CoV-2 in 2020 were more pathogenic than later variants. This is consistent with typical viral adaptive evolution to more infectious but less pathogenic strains, a natural phenomenon
-
SARS-CoV-2 spike protein is pathogenic, whether from the virus or created from genetic code in mRNA and adenovectorDNA vaccines.
-
further suggests the possibility of intergenerational transmission if germline cells incorporate the DNA copy into the host genome
-
(‘spikeopathy’) via several mechanisms that lead to inflammation, thrombogenesis, and endotheliitis-related tissue damage
-
Interaction of the vaccine-encoded spike protein with ACE-2, P53 and BRCA1 suggests a wide range of possible biological interference with oncological potential
-
Repeated COVID-19 vaccine booster doses appear to induce tolerance and may contribute to recurrent COVID-19 infection and ‘long COVID’.
AHR signaling is induced by infection with coronaviruses - PMC - 0 views
www.ncbi.nlm.nih.gov/...PMC8390748
COVID COVID-19 SARS-CoV-2 AHR aryl hydrocarbon receptors COVID19 aryl hydrocarbon
